To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
Filters
GALC Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse GALC for immunoblotting applications. Estimated Availability: Late 2025
INPP5F Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse INPP5F for immunoblotting and immunostaining applications. Estimated Availability: Late 2025
Miro1 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse Miro1 for immunocytochemistry applications. Estimated Availability: Late 2025
PINK1 pS228 Phosphospecific Antibody
Antibody
Rabbit monoclonal phosphospecific antibody directed against Serine 228 of PINK1 (pS228 PINK1). Developed for use in immunoblotting applications.Expected Availability: Late 2025
Rab 12 pS106 Phosphospecific Antibody (WB/PRM-MS)
Antibody
Rabbit monoclonal antibody directed against human/mouse Rab12 when phosphorylated at Serine106 (pS106 Rab12). Developed for use in immunostaining and PRM-MS applications. Estimated Availability: Late 2025
SCD5 Antibody
Antibody
Rabbit monoclonal antibody directed against human SCD5 for immunoblotting and immunostaining applications. Estimated Availability: Late 2025
TMEM175 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse TMEM175. Developed for us in immunoblotting and immunostaining applications. Estimated Availability: Late 2025
Eif2ak1 Knockout RAW264.7 Cell Line
Immortalized Cell
RAW264.7 cell line with homozygous knockout of Eif2ak1. Anticipated Availability: Q4 2026
CLN3 Knockout HCT-116 Cell Line
Immortalized Cell
HCT-116 cell line with homozygous knockout of CLN3. This cell line development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Anticipated Availability: Q4 2026
ITPKB Knockout PC-3 Cell Line
Immortalized Cell
PC-3 cell line with homozygous knockout of ITPKB. This cell line development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Anticipated Availability: Q4 2026
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic